SCA
HCR

Salient Capital Advisors’s Hi-Crush Inc. Common Stock HCR Stock Holding History

Salient Capital Advisors’s Portfolio HCR Stock Details HCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-438,746
Closed -$7.61M – 254
2017
Q1 		$7.61M Buy
+438,746
New +$8.11M 0.14% 53
2014
Q4 		– Sell
-54,357
Closed -$2.8M – 256
2014
Q3 		$2.8M Sell
54,357
-21,643
-28% -$1.35M 0.05% 99
2014
Q2 		$4.98M Buy
+76,000
New +$3.54M 0.11% 68

Other funds holding HCR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
LCM
Lafitte Capital Management Austin, Texas $49.5M AUM 27.1% 1-Year Est. Return

Salient Capital Advisors's HCR Position: Q2 2017 in Review

Salient Capital Advisors sold out of Hi-Crush Inc. Common Stock (HCR) in Q2 2017, closing a stake of 438,746 shares — an estimated $7.61M sold.

Salient Capital Advisors first reported a position in HCR in Q2 2014 and held it in 3 quarters. The position peaked at $7.61M in Q1 2017. 107 funds tracked by Wall St. Rank hold HCR as of Q2 2017.

  • Salient Capital Advisors reported no remaining Hi-Crush Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Salient Capital Advisors sold 438,746 Hi-Crush Inc. Common Stock shares in Q2 2017, an estimated $7.61M.
  • Salient Capital Advisors first reported a position in Hi-Crush Inc. Common Stock in Q2 2014 and held it in 3 quarters.
  • Salient Capital Advisors's Hi-Crush Inc. Common Stock position peaked at $7.61M in Q1 2017.
  • 107 funds tracked by Wall St. Rank held Hi-Crush Inc. Common Stock as of Q2 2017.

Based on Salient Capital Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.